Campanelli Paul
Insider CIK 1392459 · ENDP President, Par Pharmaceutical, Director · CNVY Director · PRX Chief Operating Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNVY Convey Health Solutions Ho | D To issuer deriv | 2022-10-07 | 2022-10-12 | 27,125 | — | $0 | 0 | SEC↗ |
| CNVY Convey Health Solutions Ho | A Award deriv | 2022-03-28 | 2022-03-30 | 27,125 | — | $0 | 27,125 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2021-04-06 | 2021-04-06 | 188,384 | $7.37 | $1.39M | 1,607,550 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2021-04-06 | 2021-04-06 | 300,000 | — | $0 | 1,523,403 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2021-04-06 | 2021-04-06 | 368,300 | — | $0 | 1,795,934 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2021-04-02 | 2021-04-06 | 146,400 | $7.37 | $1.08M | 1,427,634 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2021-03-29 | 2021-03-31 | 72,926 | $7.31 | $533.1K | 1,274,034 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-08-10 | 2020-08-12 | 69,539 | $3.40 | $236.4K | 1,147,946 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-08-10 | 2020-08-12 | 47,250 | $3.40 | $160.7K | 1,197,521 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-04-02 | 2020-04-06 | 146,400 | $3.16 | $462.6K | 1,074,985 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-03-29 | 2020-03-31 | 72,926 | $3.52 | $256.7K | 921,385 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2020-02-25 | 2020-02-25 | 227,445 | — | $0 | 845,143 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-02-25 | 2020-02-25 | 92,976 | $6.19 | $575.5K | 844,871 | SEC↗ |
| ENDP Endo International plc | M Exercise | 2020-02-25 | 2020-02-25 | 208,430 | — | $0 | 937,847 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-02-23 | 2020-02-25 | 998 | $6.19 | $6.2K | 729,417 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2020-02-21 | 2020-02-25 | 24,184 | $6.19 | $149.7K | 727,460 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-09-28 | 2019-10-01 | 1,874 | $3.12 | $5.8K | 675,829 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-08-10 | 2019-08-13 | 69,539 | $2.49 | $173.2K | 624,287 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-08-10 | 2019-08-13 | 47,251 | $2.49 | $117.7K | 673,862 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-04-02 | 2019-04-04 | 146,400 | $8.10 | $1.19M | 551,326 | SEC↗ |
| ENDP Endo International plc | A Award | 2019-03-31 | 2019-04-02 | 448,318 | — | $0 | 2,006,405 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-02-23 | 2019-02-26 | 998 | $10.51 | $10.5K | 397,726 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2019-02-21 | 2019-02-25 | 24,184 | $10.38 | $251.0K | 395,769 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2018-09-28 | 2018-10-02 | 1,801 | $16.71 | $30.1K | 344,138 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2018-08-10 | 2018-08-14 | 70,180 | $15.82 | $1.11M | 342,097 | SEC↗ |
| ENDP Endo International plc | A Award | 2018-07-31 | 2018-08-02 | 290,476 | — | $0 | 1,783,199 | SEC↗ |
| ENDP Endo International plc | A Award | 2018-04-02 | 2018-04-04 | 900,000 | — | $0 | 1,492,723 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2018-02-23 | 2018-02-27 | 942 | $6.78 | $6.4K | 269,777 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2018-02-21 | 2018-02-22 | 24,184 | $6.72 | $162.5K | 267,763 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2017-09-28 | 2017-10-02 | 1,330 | $8.38 | $11.1K | 216,132 | SEC↗ |
| ENDP Endo International plc | P Buy | 2017-08-14 | 2017-08-15 | 6,500 | $7.71 | $50.1K | 213,620 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2017-08-10 | 2017-08-11 | 971,590 | — | $0 | 971,590 | SEC↗ |
| ENDP Endo International plc | A Award | 2017-08-10 | 2017-08-11 | 427,500 | — | $0 | 675,336 | SEC↗ |
| ENDP Endo International plc | P Buy | 2017-03-16 | 2017-03-16 | 2,300 | $10.72 | $24.7K | 207,120 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2017-02-23 | 2017-02-27 | 1,066 | $13.22 | $14.1K | 204,820 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2017-02-21 | 2017-02-23 | 510,204 | — | $0 | 510,204 | SEC↗ |
| ENDP Endo International plc | A Award | 2017-02-21 | 2017-02-23 | 227,445 | — | $0 | 250,792 | SEC↗ |
| ENDP Endo International plc | F Tax w/h | 2016-09-28 | 2016-09-28 | 1,981 | $22.26 | $44.1K | 202,930 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2016-09-26 | 2016-09-28 | 429,645 | — | $0 | 429,645 | SEC↗ |
| ENDP Endo International plc | P Buy | 2016-05-10 | 2016-05-11 | 13,000 | $15.53 | $201.9K | 201,069 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2016-02-23 | 2016-02-25 | 39,875 | — | $0 | 39,875 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-02-23 | 2016-02-25 | 23,645 | — | $0 | 129,111 | SEC↗ |
| ENDP Endo International plc | A Award | 2016-02-23 | 2016-02-25 | 11,822 | — | $0 | 27,189 | SEC↗ |
| ENDP Endo International plc | P Buy | 2015-11-11 | 2015-11-12 | 1,900 | $55.62 | $105.7K | 187,869 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-11-11 | 2015-11-12 | 2,100 | — | $0 | 105,466 | SEC↗ |
| ENDP Endo International plc | P Buy | 2015-11-11 | 2015-11-12 | 200 | $56.38 | $11.3K | 188,069 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-11-03 | 2015-11-05 | 72,632 | — | $0 | 103,366 | SEC↗ |
| ENDP Endo International plc | A Award deriv | 2015-09-28 | 2015-09-30 | 56,920 | — | $0 | 56,920 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-09-28 | 2015-09-30 | 15,367 | — | $0 | 15,367 | SEC↗ |
| ENDP Endo International plc | A Award | 2015-09-28 | 2015-09-30 | 30,734 | — | $0 | 30,734 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 17,789 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 17,593 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 27,000 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 22,771 | $36.94 | $841.2K | 27,000 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 34,290 | $39.01 | $1.34M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 50,875 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 4,497 | $16.38 | $73.7K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 8,970 | $7.86 | $70.5K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 25,438 | $50.00 | $1.27M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 25,438 | $50.00 | $1.27M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 3,175 | $25.73 | $81.7K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer | 2012-09-28 | 2012-10-02 | 46,017 | $50.00 | $2.30M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | F Tax w/h | 2012-01-11 | 2012-01-13 | 1,102 | $35.65 | $39.3K | 46,106 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | F Tax w/h | 2012-01-06 | 2012-01-09 | 806 | $34.01 | $27.4K | 47,118 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-05 | 2012-01-09 | 25,438 | — | $0 | 25,438 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-05 | 2012-01-09 | 50,875 | — | $0 | 50,875 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-05 | 2012-01-09 | 25,438 | — | $0 | 25,438 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | F Tax w/h | 2012-01-04 | 2012-01-06 | 1,062 | $32.17 | $34.2K | 47,924 | SEC↗ |